Approval · Notice of Compliance 1665 · 1999
CELEXA: Notice of Compliance 1665
Issued February 5, 1999
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 1665
- Date
- February 5, 1999
- Company
- Lundbeck Canada IncSt-Laurent, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
- Therapeutic class
- Antidepressant
Products in this notice
Medicinal ingredients
- CITALOPRAM HYDROBROMIDE 10 MG per TAB
- CITALOPRAM HYDROBROMIDE 20 MG per TAB
- CITALOPRAM HYDROBROMIDE 40 MG per TAB